Literature DB >> 3491174

Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome.

D Y Leung, R S Geha, J W Newburger, J C Burns, W Fiers, L A Lapierre, J S Pober.   

Abstract

Kawasaki syndrome (KS) is an acute febrile illness of early childhood characterized by diffuse vasculitis and marked immune activation. The present study was undertaken to determine whether the acute phase of KS is associated with circulating cytotoxic antibodies directed to target antigens induced on vascular endothelium by the monokines, IL-1, or tumor necrosis factor (TNF). Sera from 20 patients with acute KS, 11 patients in the convalescent phase of KS, and 17 age-matched controls were assessed for complement-dependent cytotoxic activity against 111In-labeled human endothelial cells (HEC), dermal fibroblasts, and vascular smooth muscle cells. Sera from patients with acute KS but not the other subject groups caused significant (p less than 0.01) complement-mediated killing of IL-1- or TNF-stimulated HEC. None of the sera tested had cytotoxicity against control HEC cultures or the other target cell types, with or without IL-1 or TNF pretreatment. Expression of the IL-1- or TNF-inducible target antigens on endothelial cells was rapid and transient, peaking at 4 h and disappearing after 24 h despite continued incubation with monokine. In contrast, we have previously shown that IFN-gamma requires 72 h to render HEC susceptible to lysis with acute KS sera. Serum adsorption studies demonstrated that IL-1- and TNF-inducible endothelial target antigens are distinct from IFN-gamma-inducible antigens. These observations suggest that mediator secretion by activated monocyte/macrophages could be a predisposing factor to the development of vascular injury in acute KS. Although our present observations have been restricted to KS, the development of cytotoxic antibodies directed to monokine-inducible endothelial cell antigens may also be found in other vasculitides accompanied by immune activation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491174      PMCID: PMC2188474          DOI: 10.1084/jem.164.6.1958

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

Review 1.  Culture of vascular endothelium.

Authors:  M A Gimbrone
Journal:  Prog Hemost Thromb       Date:  1976

2.  Isolation and structure of a human fibroblast interferon gene.

Authors:  R Derynck; J Content; E DeClercq; G Volckaert; J Tavernier; R Devos; W Fiers
Journal:  Nature       Date:  1980-06-19       Impact factor: 49.962

3.  T cell growth factor: parameters of production and a quantitative microassay for activity.

Authors:  S Gillis; M M Ferm; W Ou; K A Smith
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

4.  Ability of human leukocytic pyrogen to enhance phytohemagglutinin induced murine thymocyte proliferation.

Authors:  L J Rosenwasser; C A Dinarello
Journal:  Cell Immunol       Date:  1981-09-01       Impact factor: 4.868

5.  Immunoregulatory abnormalities in mucocutaneous lymph node syndrome.

Authors:  D Y Leung; R L Siegel; S Grady; A Krensky; R Meade; E L Reinherz; R S Geha
Journal:  Clin Immunol Immunopathol       Date:  1982-04

6.  Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome.

Authors:  H Kato; S Koike; M Yamamoto; Y Ito; E Yano
Journal:  J Pediatr       Date:  1975-06       Impact factor: 4.406

7.  Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lymph node syndrome the same? Comparison of 20 patients from North America with patients from Hawaii and Japan.

Authors:  B H Landing; E J Larson
Journal:  Pediatrics       Date:  1977-05       Impact factor: 7.124

8.  Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome. A skin biopsy study of 27 patients.

Authors:  S Hirose; Y Hamashima
Journal:  Eur J Pediatr       Date:  1978-08-17       Impact factor: 3.183

9.  The human fibroblast and human immune interferon genes and their expression in homologous and heterologous cells.

Authors:  W Fiers; E Remaut; R Devos; H Cheroutre; R Contreras; D Gheysen; W Degrave; P Stanssens; J Tavernier; Y Taya; J Content
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1982-09-24       Impact factor: 6.237

10.  Pathology of the heart in Kawasaki disease.

Authors:  H Fujiwara; Y Hamashima
Journal:  Pediatrics       Date:  1978-01       Impact factor: 7.124

View more
  64 in total

Review 1.  Anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies.

Authors:  M J Dillon; E J Tizard
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

2.  Antineutrophil cytoplasm antibodies in Kawasaki disease.

Authors:  C O Savage; J Tizard; D Jayne; C M Lockwood; M J Dillon
Journal:  Arch Dis Child       Date:  1989-03       Impact factor: 3.791

3.  Antibodies to native type III collagen in the serum of patients with Kawasaki disease.

Authors:  S Kobayashi; N Wada; M Kubo
Journal:  Eur J Pediatr       Date:  1992-03       Impact factor: 3.183

Review 4.  The immunoregulatory effects of IVIG in Kawasaki disease and other autoimmune diseases.

Authors:  D Y Leung
Journal:  Clin Rev Allergy       Date:  1992 Spring-Summer

Review 5.  The endothelium: its role in scleroderma.

Authors:  J D Pearson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 6.  Immunological features of diffuse connective tissue diseases.

Authors:  G R Burgio; A Martini
Journal:  Eur J Pediatr       Date:  1990-01       Impact factor: 3.183

7.  Staphylococcus aureus isolates from patients with Kawasaki disease express high levels of protein A.

Authors:  E R Wann; A P Fehringer; Y V Ezepchuk; P M Schlievert; P Bina; R F Reiser; M M Höök; D Y Leung
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

8.  Monitoring the acute phase response: comparison of tumour necrosis factor (cachectin) and C-reactive protein responses in inflammatory and infectious diseases.

Authors:  C P Maury
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

9.  Cytokines predict coronary aneurysm formation in Kawasaki disease patients.

Authors:  C Y Lin; C C Lin; B Hwang; B N Chiang
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

10.  Anti-endothelial cell antibodies in nephropathia epidemica and other viral diseases.

Authors:  A G Wangel; M Temonen; M Brummer-Korvenkontio; A Vaheri
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.